Shares of Honasa Consumer, the parent company of Mamaearth, jumped as much as 8.5% on Thursday to Rs 222.10 on the BSE after the company reported a consolidated net profit of Rs 26 crore for the December quarter, largely unchanged from Rs 25.9 crore in the year-ago period.Revenue from operations in Q3FY25 stood at Rs 518 crore, marking a 6% increase from Rs 488 crore reported in the corresponding quarter last year. Sequentially, the topline grew 12% from Rs 462 crore in Q2FY25, when the company posted a net loss of Rs 19 crore.Mamaearth's earnings before interest, taxes, depreciation and amortisation (EBITDA) margin for Q3FY25 stood at 5%.In an exchange filing, Honasa Consumer said the 6% revenue uptick signals growth momentum with Mamaearth growing in market share and household penetration. The brand reached 2,16,814 FMCG retail outlets in India as of December 2024, increasing distribution by 22% YoY, the company said citing NielsenIQ.Mamaearth face wash gained +114 bps and shampoo gained +20bps in value market share YoY, reflecting strong brand equity as per NielsenIQ.Also Read: Stocks in news: Hindalco, SJVN, Honasa Consumer, ICICI Bank, Tata PowerHonasa Consumer Q3 business updatesUnder Project Neev, the company has successfully completed the appointment of Tier-1 distributors in all top 50 cities.The Derma Co., Aqualogica, BBlunt, and Dr. Sheth’s maintained strong momentum, delivering over 30% YTD YoY growth, reinforcing their contribution to overall business growth.The focus categories viz. face wash, shampoo, serum, moisturizer, sun care, and baby care — grew 18% in 9MFY25 (adjusted for one-time inventory correction in Q2FY25).For 9MFY25, revenue reached Rs1,533 crore, up 5.8% YoY, while revenue when adjusted for one-time inventory correction in Q2FY25 stood at Rs 1,596 crore, a 10.2% YoY growth.Newer channels like quick-commerce continue to perform well, growing over 200% YoY in 9MFY25.Honasa Consumer shares target priceAs per Trendlyne data, the average target price of the stock is Rs 366, which indicates an upside of 79% from the current market prices. The consensus recommendation from 12 analysts for the stock is a 'Hold'.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)